ArticleRedox biology2026
Compensation for impaired sensing of selenoprotein deficiency by alternative cysteine residues in KEAP1.
Article in Redox biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The KEAP1-NRF2 system is a master regulator of cellular defense against oxidative and electrophilic stresses. Cysteine residues within KEAP1 function as critical stress sensors. While KEAP1-Cys151 is a well-established sensor for electrophilic NRF2 activators, its contribution to the oxidative stress response remains unclear. Here, we investigated NRF2 activation in Cys151-deficient mice under hepatocyte-specific disruption of selenoprotein synthesis, a condition associated with profound redox imbalance. NRF2 activation and hepatic homeostasis were preserved in these mice, indicating that Cys151 is dispensable for sensing of selenoprotein deficiency. Conversely, loss of Cys226/Cys613-mediated sensing impaired NRF2 activation, leading to severe liver injury and lethality. Importantly, treatment with the Cys151-dependent electrophilic activator CDDO-Im restored NRF2 activity and improved survival in mice lacking functional Cys226/Cys613 sensing. Together, these findings demonstrate that individual KEAP1 cysteine residues have distinct functional roles in stress sensing, yet their signals converge on a common pathway to regulate NRF2 activation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.